Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis (EMG-BFB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02974465
Recruitment Status : Completed
First Posted : November 28, 2016
Last Update Posted : December 11, 2018
Sponsor:
Information provided by (Responsible Party):
Cristina Lirio Romero, University of Alcala

Brief Summary:
The aim of this study was to assess the effect of a specific protocol of sEMG-BFB in upper limb hemiparesis added to conventional physical therapy on changes in upper extremity functionality, motor recruitment pattern and range of motion (ROM) compared to the single application of conventional physical therapy. It aims to find a 22.22% difference between both interventions.

Condition or disease Intervention/treatment Phase
Electromyography Procedure: Biofeedback Electromyography Procedure: Sham Biofeedback Electromyography Procedure: Conventional Physical Therapy Treatment Not Applicable

Detailed Description:

Upper limb hemiparesis is a common consequence after brain damage.

Objective: To evaluate the effect of a specific protocol of surface electromyographic biofeedback (sEMG-BFB) and conventional physical therapy in upper limb functionality, muscle recruitment changes, and glenohumeral range of motion compared to the single application of conventional physical therapy.

Design: randomized controlled clinical trial.

Sample: 40 participants from State Center of Attention to Brain Injury were recruited.

Interventions: Patients were randomly assigned to 2 groups where the experimental group received sEMG-BFB for the upper trapezius and middle deltoid muscles of the upper limb with hemiparesis and the control group received a placebo of the same technique. Both treatments were applied for 6 weeks. The score of the Fugl-Meyer Assessment-Upper Extremity" for functionality and shoulder range of motion were objectified. Root mean square (RMS) value was assessed as a secondary measure Data were collected before and after intervention.

A protocol of sEMG-BFB in upper limb may have an important role in the recovery of subjects with upper limb hemiparesis.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis: A Randomized Controlled Clinical Trial
Study Start Date : November 2016
Actual Primary Completion Date : September 2017
Actual Study Completion Date : February 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup

Arm Intervention/treatment
Experimental: Experimental Group
protocol of Biofeedback Electromyography plus conventional physical therapy treatment
Procedure: Biofeedback Electromyography
protocol of sEMG-BFB that consisted of active movements in glenohumeral abduction guided by the visual signal of the register equipment. The protocol was the following: firstly proof active movements were requested in glenohumeral abduction without feeling any pain in order to teach the visual signal of their muscle activity. The therapist dedicated around 10 minutes in each session for subject learned to control the activation of both muscles in the limits that physical therapist marked with each individual in particular (controlling the activation in the upper trapezius). Once integrated information, shoulder abduction were requested following 4 main principles.

Procedure: Conventional Physical Therapy Treatment
All participants received a conventional daily treatment of neurological physical therapy. Since no evidence has been found about a specific therapy that specially could benefit hemiparesis consequences, the common approach in this center consists of a combination of different specific concepts (Bobath, Brunnstrom, Rood, Johnstone, Propioceptive Neuromuscular Facilitation, Perfetti, Vojta, Motor Relearning Programme,…), exercise programs, electrotherapy, myofascial techniques, etc…

Sham Comparator: Control Group
consisted of Sham- Biofeedback Electromyography plus conventional physical therapy treatment
Procedure: Sham Biofeedback Electromyography
consisted of Sham-EMG biofeedback, in which the electrodes were placed as the same method as the EG (Fig. 2) but the screen emit no signal. The subject performed 3 sequences of 10 abduction contractions (first degrees) without pain feeling and with 5 minutes of rest between sequences.

Procedure: Conventional Physical Therapy Treatment
All participants received a conventional daily treatment of neurological physical therapy. Since no evidence has been found about a specific therapy that specially could benefit hemiparesis consequences, the common approach in this center consists of a combination of different specific concepts (Bobath, Brunnstrom, Rood, Johnstone, Propioceptive Neuromuscular Facilitation, Perfetti, Vojta, Motor Relearning Programme,…), exercise programs, electrotherapy, myofascial techniques, etc…




Primary Outcome Measures :
  1. Fugl-Meyer Upper-Extremity Scale (FMA-UE) [ Time Frame: 15 minutes ]
    Assess functionality found in the motor recruitment of the paretic shoulder muscles after brain injury


Secondary Outcome Measures :
  1. range of motion [ Time Frame: 10 minutes ]
    Articular goniometer



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 55 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • acquired brain injury after two months of medical evolution at least;
  • suffer paretic upper limb;
  • spasticity no greater than 3 in the modified Ashworth scale;
  • minimum active ROM of 20º of glenohumeral abduction.

Exclusion Criteria:

  • peripheral nerve injury, fractures of upper limb, cervical radiculopathy, complete luxation of the shoulder and severe cognitive impairment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02974465


Sponsors and Collaborators
University of Alcala
Investigators
Layout table for investigator information
Study Director: Maria Torres Lacomba, PhD University of Alcalá
Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Cristina Lirio Romero, Physiotherapist, University of Alcala
ClinicalTrials.gov Identifier: NCT02974465    
Other Study ID Numbers: UNIALCALA
First Posted: November 28, 2016    Key Record Dates
Last Update Posted: December 11, 2018
Last Verified: November 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Cristina Lirio Romero, University of Alcala:
Brain injuries
upper extremity
biofeedback
electromyography
recovery of function
Additional relevant MeSH terms:
Layout table for MeSH terms
Paresis
Neurologic Manifestations
Nervous System Diseases